Murine model of long-term obstructive jaundice

Journal of Surgical Research

Volumn 206, Issue 1, 2016, Pages 118-125

  Aoki, Hiroaki ^a   Aoki, Masayo ^a   Yang, Jing ^a   Katsuta, Eriko ^a   Mukhopadhyay, Partha ^a   Ramanathan, Rajesh ^a   Woelfel, Ingrid A ^a   Wang, Xuan ^a   Spiegel, Sarah ^a   Zhou, Huiping ^a   Takabe, Kazuaki ^a,b  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

Bile acid; bile acid; Bile duct; Cholestasis; Mouse; Murine model; Obstructive jaundice

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILE ACID; COLLAGEN; COLLAGEN 1A1; UNCLASSIFIED DRUG;

ABDOMINAL BLEEDING; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILE ACID BLOOD LEVEL; BILE DUCT INJURY; BILE DUCT LIGATION; BODY WEIGHT; COMMON BILE DUCT; CONTROLLED STUDY; DUODENUM HEMATOMA; GALLBLADDER; INTRA ABDOMINAL BLEEDING; INTRAHEPATIC BILE DUCT; LIVER FIBROSIS; LIVER INJURY; LIVER NECROSIS; LIVER REGENERATION; LIVER WEIGHT; MALE; MORTALITY; MOUSE; NONHUMAN; OBSTRUCTIVE JAUNDICE; PORTAL HYPERTENSION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN WEIGHT; SPLENOMEGALY; SURGICAL STRESS; SURVIVAL; ANIMAL; C57BL MOUSE; CHOLECYSTECTOMY; COMMON HEPATIC DUCT; COMPARATIVE STUDY; DISEASE MODEL; FEASIBILITY STUDY; KAPLAN MEIER METHOD; LIGATION; PATHOLOGY; PATHOPHYSIOLOGY; SURGERY;

ANIMALS; CHOLECYSTECTOMY; COMMON BILE DUCT; DISEASE MODELS, ANIMAL; FEASIBILITY STUDIES; HEPATIC DUCT, COMMON; JAUNDICE, OBSTRUCTIVE; KAPLAN-MEIER ESTIMATE; LIGATION; MALE; MICE; MICE, INBRED C57BL;

EID: 84981274466     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2016.07.020     Document Type: Article

References (29)

1. 1 Liu, R., Li, X., Luo, L., et al. Taurocholate induces Cyclooxygenase-2 expression via the sphingosine 1-phosphate receptor 2 in a human cholangiocarcinoma cell line. J Biol Chem 290 (2015), 30988–31002.
2. 2 Liu, R., Zhao, R., Zhou, X., et al. Conjugated bile acids promote cholangiocarcinoma cell invasive growth through activation of sphingosine 1-phosphate receptor 2. Hepatology 60 (2014), 908–918.
3. 3 Yang, H., Li, T.W.H., Peng, J., et al. A mouse model of cholestasis-associated cholangiocarcinoma and transcription factors involved in progression. Gastroenterology 141 (2011), 378–388.
4. 4 Park, M.A., Zhang, G., Norris, J., et al. Regulation of autophagy by ceramide-CD95-PERK signaling. Autophagy 4 (2008), 929–931.
5. 5 Studer, E., Zhou, X., Zhao, R., et al. Conjugated bile acids activate the sphingosine-1-phosphate receptor 2 in primary rodent hepatocytes. Hepatology 55 (2012), 267–276.
6. 6 Nagahashi, M., Takabe, K., Liu, R., et al. Conjugated bile acid-activated S1P receptor 2 is a key regulator of sphingosine kinase 2 and hepatic gene expression. Hepatology 61 (2015), 1216–1226.
7. 7 Ueno, K., Ajiki, T., Watanabe, H., et al. Changes in extrathymic T cells in the liver and intestinal intraepithelium in mice with obstructive jaundice. World J Surg 28 (2004), 277–282.
8. 8 Miyoshi, H., Rust, C., Roberts, P.J., Burgart, L.J., Gores, G.J., Hepatocyte apoptosis after bile duct ligation in the mouse involves Fas. Gastroenterology 117 (1999), 669–677.
9. 9 Licata, L.A., Nguyen, C.T., Burga, R.A., et al. Biliary obstruction results in PD-1-dependent liver T cell dysfunction and acute inflammation mediated by Th17 cells and neutrophils. J Leukoc Biol 94 (2013), 1–11.
10. 10 Tiao, M.-M., Wang, F.-S., Huang, L.-T., et al. MicroRNA-29a protects against acute liver injury in a mouse model of obstructive jaundice via inhibition of the extrinsic apoptosis pathway. Apoptosis 19 (2014), 30–41.
11. 11 Tag, C.G., Sauer-Lehnen, S., Weiskirchen, S., et al. Bile duct ligation in mice: induction of inflammatory liver injury and fibrosis by obstructive cholestasis. J Vis Exp, 2015, 1–11.
12. 12 Heinrich, S., Georgiev, P., Weber, A., Vergopoulos, A., Graf, R., Clavien, P.A., Partial bile duct ligation in mice: a novel model of acute cholestasis. Surgery 149 (2011), 445–451.
13. 13 Kirkland, J.G., Godfrey, C.B., Garrett, R., Kakar, S., Yeh, B.M., Corvera, C.U., Reversible surgical model of biliary inflammation and obstructive jaundice in mice. J Surg Res 164 (2010), 221–227.
14. 14 Wu, J., Song, L., Zhang, Y., Zhao, D.Y., Guo, B., Liu, J., Efficacy of percutaneous transhepatic cholangiodrainage (PTCD) in patients with unresectable pancreatic cancer. Tumour Biol 35 (2014), 2753–2757.
15. 15 Kloek, J.J., van der Gaag, N.A., Aziz, Y., et al. Endoscopic and percutaneous preoperative biliary drainage in patients with suspected hilar cholangiocarcinoma. J Gastrointest Surg 14 (2010), 119–125.
16. 16 Kawakami, H., Kuwatani, M., Onodera, M., et al. Endoscopic nasobiliary drainage is the most suitable preoperative biliary drainage method in the management of patients with hilar cholangiocarcinoma. J Gastroenterol 46 (2011), 242–248.
17. 17 Kawashima, H., Itoh, A., Ohno, E., et al. Preoperative endoscopic nasobiliary drainage in 164 consecutive patients with suspected perihilar cholangiocarcinoma: a retrospective study of efficacy and risk factors related to complications. Ann Surg 257 (2013), 121–127.
18. 18 Iacono, C., Ruzzenente, A., Campagnaro, T., Bortolasi, L., Valdegamberi, A., Guglielmi, A., Role of preoperative biliary drainage in jaundiced patients who are candidates for pancreatoduodenectomy or hepatic resection: highlights and drawbacks. Ann Surg 257 (2013), 191–204.
19. 19 Nagino, M., Takada, T., Miyazaki, M., et al. Japanese Association of Biliary Surgery Japanese Society of Hepato-Biliary-Pancreatic Surgery, Japan Society of Clinical Oncology. Preoperative biliary drainage for biliary tract and ampullary carcinomas. J Hepatobiliary Pancreat Surg 15 (2008), 25–30.
20. 20 Nimura, Y., Kamiya, J., Kondo, S., et al. Aggressive preoperative management and extended surgery for hilar cholangiocarcinoma: Nagoya experience. J Hepatobiliary Pancreat Surg 7 (2000), 155–162.
21. 21 Fang, Y., Wang, Q., Ks, G., Lin, H., Xie, X., Wang, C., Preoperative biliary drainage for obstructive jaundice. Cochrane Database Syst Rev, 2012, CD005444.
22. 22 Xu, Z., Tavares-Sanchez, O.L., Li, Q., et al. Activation of bile acid biosynthesis by the p38 mitogen-activated protein kinase (MAPK): hepatocyte nuclear factor-4 phosphorylation by the p38 MAPK is required for cholesterol 7 -hydroxylase expression. J Biol Chem 282 (2007), 24607–24614.
23. 23 Zhang G, Park M, Mitchell C, Walker T, Hamed H, Studer E, et al. Multiple cyclin kinase inhibitors promote bile acid-induced apoptosis and autophagy in primary hepatocytes via p53-CD95-dependent signaling 2008. http://www.jbc.org/content/283/36/24343.full.pdf (Accessed 2016).
24. 24 Hylemon, P.B., Zhou, H., Pandak, W.M., Ren, S., Gil, G., Dent, P., Bile acids as regulatory molecules. Jlipid Res 50 (2009), 1509–1520.
25. 25 Dai, J., Wang, H., Shi, Y., Dong, Y., Zhang, Y., Wang, J., Impact of bile acids on the growth of human cholangiocarcinoma via FXR. J Hematol Oncol, 4, 2011, 41.
26. 26 Petersen, C., Grasshoff, S., Luciano, L., Diverse morphology of biliary atresia in an animal model. J Hepatol 28 (1998), 603–607.
27. 27 Popov, Y., Patsenker, E., Fickert, P., Trauner, M., Schuppan, D., Mdr2 (Abcb4)-/- mice spontaneously develop severe biliary fibrosis via massive dysregulation of pro- and antifibrogenic genes. J Hepatol 43 (2005), 1045–1054.
28. 28 Smit, J.J., Schinkel, A.H., Oude Elferink, R.P., et al. Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease. Cell 75 (1993), 451–462.
29. 29 Tag, C., Weiskirchen, S., Hittatiya, K., Tacke, F., Tolba, R., Weiskirchen, R., Induction of experimental obstructive cholestasis in mice. Lab Anim 49 (2015), 70–80.